ADVANCED MALIGNANT TUMORS
Clinical trials for ADVANCED MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancer patients as experimental drug enters human testing
Disease control OngoingThis early-stage study tests a new drug called SG2918 in 17 people with advanced cancers that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose. Researchers will also look for early signs that the drug might shri…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental drug, BMS-986488, given alone or with other treatments, in adults with advanced solid tumors that have not responded to standard therapy. The main goals are to check safety and find the right dose. About 437 participants with specific cancer types…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New antibody cocktail targets tough tumors
Disease control OngoingThis study tests two experimental drugs (AK112 and AK117) given together to people with advanced solid tumors that have not responded to other treatments. The goal is to see if the combination is safe and can shrink or control the tumors. About 154 adults aged 18 to 75 are taking…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 18, 2026 11:59 UTC